Double-blind dose reduction study of vigabatrin in complex partial epilepsy.

Abstract

Seventy-five epilepsy patients with at least two complex partial seizures/month were treated with gamma-vinyl GABA (GVG) 3 g/day for 3 months. Forty-one patients (54%) showed a reduction of greater than or equal to 50% in seizures. The median monthly seizure frequency decreased from 11.5 to 4 seizures/month. Twenty percent of patients had an improvement in general performance without a significant reduction in seizures. The responders entered the second phase of the study, in which 28 patients were randomly allocated to 3 g/day and 25 patients to 1.5 g/day GVG under double-blind conditions. The dosage of 3 g/day appeared to be clearly more effective than 1.5 g/day. However, even with 1.5 g/day GVG the seizure frequency was significantly reduced as compared to baseline. Drowsiness was the most commonly observed side effect, and it diminished with continued treatment. In three cases side effects led to the withdrawal of GVG therapy.

Statistics

050100'95'98'01'04'07'10'13'16
Citations per Year

122 Citations

Semantic Scholar estimates that this publication has 122 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Sivenius1987DoubleblindDR, title={Double-blind dose reduction study of vigabatrin in complex partial epilepsy.}, author={M R Sivenius and Aarne Ylinen and K. E. Murros and Riitta Matilainen and Paavo J. Riekkinen}, journal={Epilepsia}, year={1987}, volume={28 6}, pages={688-92} }